Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

NCT03617939 ·Status: RECRUITING

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NCT03017573 ·Status: RECRUITING ·Phase: NA

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

NCT01209299 ·Status: COMPLETED

Collection of Biological Specimens and Associated Health Information

NCT06369441 ·Status: NOT_YET_RECRUITING

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

NCT00757614 ·Status: UNKNOWN

Molecular Markers in Cancers and Precancers (MOCA)

NCT05257707 ·Status: WITHDRAWN ·Phase: NA

Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

NCT05854368 ·Status: RECRUITING ·Phase: NA

Molecular Screening for Cancer Treatment Optimization

NCT01566019 ·Status: UNKNOWN ·Phase: NA

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT01034033 ·Status: RECRUITING

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

NCT00349830 ·Status: RECRUITING

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

NCT00899769 ·Status: COMPLETED

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

NCT00898430 ·Status: TERMINATED

CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.

NCT02789384 ·Status: RECRUITING ·Phase: NA

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

NCT06630273 ·Status: NOT_YET_RECRUITING

Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs

NCT02458040 ·Status: WITHDRAWN

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

NCT01503619 ·Status: COMPLETED

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

NCT06827639 ·Status: NOT_YET_RECRUITING

Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

NCT06782451 ·Status: RECRUITING ·Phase: NA

Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age

NCT06357923 ·Status: RECRUITING ·Phase: NA

Tumor-Derived FGF19

NCT06068257 ·Status: RECRUITING

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204 ·Status: COMPLETED

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

NCT03892096 ·Status: COMPLETED

Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

NCT02749838 ·Status: UNKNOWN

Collection of Blood From Patients With Cancer

NCT00034216 ·Status: RECRUITING

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

NCT02105168 ·Status: UNKNOWN ·Phase: NA